A study presented at ESCMID Global 2025 shows Schistosoma haematobium infection increases cervical cancer risk, even after treatment with praziquantel. The parasite triggers harmful gene activity, impacting inflammation and tissue integrity. Post-treatment, increased blood vessel formation and reduced programmed cell death were observed. Further research is needed to confirm these findings and explore preventative measures.
